AMIT KUMAR - 10 Mar 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
10 Mar 2022
Transactions value $
$0
Form type
4
Filing time
11 Mar 2022, 15:15:30 UTC
Previous filing
07 Jan 2022
Next filing
16 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +500K $0.00 500K 10 Mar 2022 Common Stock 500K $2.74 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning March 31, 2022.